Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
CYT holding history
Cyteir Therapeutics, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CYT overviewAll 13F holders of CYTFull Q1 2025 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −2,006−100.0% | Sold out | Holders |
| Q1 2024 | 2,006 | $6.04K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2,006 | $6.10K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 2,006 | $5.70K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 2,006 | $5.22K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,006 | $3.65K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 2,006 | $3.31K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 2,006 | $4.00K | <0.1% | +2,000+33,333.3% | Added | Holders |
| Q2 2022 | 6 | $0 | 0.0% | +6 | New | Holders |